𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MT2 immunoreactivity, cellular proliferation and prognosis in B-cell non-Hodgkin's lymphoma

✍ Scribed by P. A. HALL; W. M. GREGORY; A. G. STANSFELD


Book ID
108777840
Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
151 KB
Volume
14
Category
Article
ISSN
0309-0167

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Thymic B-cell non-Hodgkin's lymphoma in
✍ Azuma, Eiichi; Nishihara, Hidehiro; Qi, Jiang; Nagai, Masataka; Hiratake, Shinya πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 776 KB

A 13-year-old male developed thymic non-Hodgkin's lymphoma. Microscopically, the tumor was composed of large cells, resembling centroblasts. Immunohistochemically, the tumor demonstrated leukocyte common antigen+, L26 (B-cell)+, UCHL1 (T-cell)-, suggesting the B-cell phenotype. In contrast to the te

Analysis of PTEN mutations and deletions
✍ Marion P. Butler; Steven I. Wang; R.S.K. Chaganti; Ramon Parsons; Riccardo Dalla πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 166 KB πŸ‘ 2 views

The PTEN gene is involved in 10q23 deletions in several types of cancer, including glioma, melanoma, endometrial and prostate carcinomas. The PTEN gene product is a dual-specificity phosphatase with putative tumor suppressor function. Deletions and rearrangements of 10q22-25 have been reported in Ο³5